|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Pulmonary/Critical Care Medicine Department Wilford Hall Medical Center, 59th Medical Group, Lackland Air Force Base, TX.
Study objective: To identify a level of coagulopathy, reported as the international normalized ratio (INR), that predicts hemorrhage following transbronchial forceps biopsy (TBBx) in an animal model.
Design: Crossover blinded study using Yucatan mini-swine (Sus scrofa).
Setting: Tertiary medical center with a dedicated animal research facility.
Study design: A two-stage study. In
stage 1, flexible fiberoptic bronchoscopy with TBBx was
performed to establish the amount of bleeding in animals with normal
coagulation systems. Animals then were administered escalating dosages
of warfarin to obtain one of several increased INR levels. The endpoint
of stage 1 was defined as the INR that resulted in a blood loss of
100 mL in
50% of the study animals. In stage 2, all the
animals were to be anticoagulated to the INR level determined in stage
1. Topical and systemic measures would then be administered in an
attempt to decrease postprocedure hemorrhage, and the results were
recorded.
Results: Eighteen animals were enrolled in the study. Despite INR levels > 10, no animals developed a hemorrhagic complication of the transbronchial forceps biopsy (TBBx). Eleven animals had INRs > 7. Four animal deaths were recorded, with three animal deaths attributed to nonpulmonary hemorrhage, each due to a ruptured ovarian cyst. One death was anesthesia related. Stage 2 of the study was not performed due to the extreme INR levels reached in the animals during stage 1 and to the lack of a procedure-related complication.
Conclusions: Our study suggests that INR elevation does not correlate with an increased risk of bleeding following TBBx in this animal model.
Key Words: bleeding fiberoptic bronchoscopy hemorrhage international normalized ratio procedure complications transbronchial biopsy
This article has been cited by other articles:
![]() |
A. Ernst, R. Eberhardt, M. Wahidi, H. D. Becker, and F. J. F. Herth Effect of Routine Clopidogrel Use on Bleeding Complications After Transbronchial Biopsy in Humans Chest, March 1, 2006; 129(3): 734 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chinsky Bleeding Risk and Bronchoscopy: In Search of the Evidence in Evidence-Based Medicine Chest, June 1, 2005; 127(6): 1875 - 1877. [Full Text] [PDF] |
||||
![]() |
M. M. Wahidi, R. Garland, D. Feller-Kopman, F. Herth, H. D. Becker, and A. Ernst Effect of Clopidogrel With and Without Aspirin on Bleeding Following Transbronchial Lung Biopsy Chest, March 1, 2005; 127(3): 961 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mitchell British Thoracic Society guidelines on diagnostic flexible bronchoscopy Thorax, February 1, 2001; 56(90001): 1i - 21. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |